Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)
NCT ID: NCT05006092
Last Updated: 2023-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1149 participants
INTERVENTIONAL
2021-09-01
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies
NCT05244278
Artificial Intelligence-assisted System in Colonoscopy
NCT06406062
Comparing Detection of Standard Colonoscopy, CAD-EYE and Combined CAD-EYE and G-EYE® Aided Colonoscopy
NCT05237310
The Influence of Artificial Intelligence (AI )Assisted Polyp Detection (Discovery System) on Visual Gaze Patterns During Real-time Colonoscopy
NCT05619614
Artificial-intelligence-based QUAntification of Size measuremeNts of Adenoma in Routine Endoscopy
NCT06040710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
surveillance endoscopy with CADe support
Endoscopy perfomed with CADe support.
ENDOMIND
CADe system for Polyp detection
conventional surveillance endoscopy
Endoscopy perfomed without CADe support.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ENDOMIND
CADe system for Polyp detection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* indication post-polypectomy surveillance endoscopy
* positive fecal immunochemical test in patients \>=50 years
Exclusion Criteria
* reasonable suspicion of familiar polyposis Syndrome
* Patient after radiation/resection of colonic parts
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinikum Stuttgart
OTHER
Wuerzburg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Hann
Role: PRINCIPAL_INVESTIGATOR
Wuerzburg University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Würzburg
Würzburg, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lux TJ, Banck M, Sassmannshausen Z, Troya J, Krenzer A, Fitting D, Sudarevic B, Zoller WG, Puppe F, Meining A, Hann A. Pilot study of a new freely available computer-aided polyp detection system in clinical practice. Int J Colorectal Dis. 2022 Jun;37(6):1349-1354. doi: 10.1007/s00384-022-04178-8. Epub 2022 May 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F-2021-047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.